Improving our knowledge on the risk factors and correct assessment of patients will significantly improve how patients are managed and support their achievement of a normal, healthy lifespan.
Over the past decade, there has been increasing work and evidence for the importance of genetics in CVD, along with the burgeoning topics of epigenetics and nutrigenomics. With greater understanding in these areas, health professionals will be able to offer more targeted, personalised therapy.
There are many misconceptions around the causes and long-term management of CVD. For too long, there has been an emphasis on cholesterol levels as a major cause for CVD. With this excessive emphasis on cholesterol, its poorer cousin, hypertension, has often been ignored. And, in many cases, it goes undetected or under-treated. This is despite the fact that hypertension is, no doubt, the chief risk factor for CVD.
Cardiovascular disease (CVD) remains the major cause of death and disability around the world, with one Australian dying every 12 minutes from some form of this condition. The most common forms of CVD are the clinical syndromes related to atherosclerosis.
Registration & Dinner 6:30pm - 7:00pm
Presentation 7:00pm - 9:00pm
Q&A 9:00pm - 9:15pm
Registration NOW OPEN
Seminar Dates Wednesday 21 February 2018
- To understand the relevance of the entire lipid profile in healthy people as well as those with evidence of atherosclerotic CVD.
- To understand the importance of insulin resistance as a central feature of atherosclerotic CVD.
understand the place of pharmaceutical and complementary therapies in
the management of hyperlipidaemia and/or atherosclerotic CVD.
- To comprehend the central role of hypertension in the generation of most forms of CVD.
- To acknowledge the role of multiple genetic and environmental factors in the generation of hypertension.
- To learn the best diagnostic approach to the treatment of people with hypertension.
- To understand the non-pharmacologic and pharmacologic approaches to the treatment of hypertension.
- To understand the role of genetics and epigenetics in CVD and diabetes.
- To define and assess the role of the emerging field of nutrigenomics.
- To understand the meaning and applicability of gene polymorphisms for the management of CVD.
Dr Walker is a leading integrative cardiologist based on the upper north shore of Sydney. He provides a service in all aspects of echocardiography, focusing on stress echocardiography, which is a well-accepted, accurate method for assessing heart disease that does not involve irradiation or injections.
Dr Walker commenced stress echocardiography in 1992 and since then, has performed over 50,000 studies, over 80,000 trans-thoracic echoes and 2,000 trans-oesophageal echoes. Stress echocardiography provides much more information to the practitioner than stress testing. He, along with Dr David Grout and the Sydney Adventist Hospital, pioneered Coronary Calcium Scoring in Australia, the most accurate preventative scene for early heart disease.
Dr Walker also specialises in the field of preventative cardiology and has commenced a related service in arterial screening, which is an indirect measure of endothelial function and arterial stiffness that also does not involve irradiation or injections.
He is the author of seven books including ‘The Life Factor’ and ‘5 Stages of Health’, and appears regularly as a media commentator including hosting a health show on the Talking Lifestyle network throughout Australia, part of the Macquarie Media Network. Dr Walker lectures on CVD both nationally and internationally